July 18, 2014 Introducing nyloxincareer Chronic Pain Does - TopicsExpress



          

July 18, 2014 Introducing nyloxincareer Chronic Pain Does Not Sleep The Pain Doctor Tells The Truth! 90% of USA Doctor Visits are Pain Related A conference call so good, you have to share it with everyone you know! After listening to this incredible call packed with 39 minutes of life-changing information, its hard to believe that two and a half months ago Dr. Brad Eli had never heard of Nyloxin. As Dr. Eli explains, there simply is not another non-prescription product in the marketplace that can even come close to helping more people than Nyloxin. With over 100 million people in the USA suffering from serious Stage 2 and Stage 3 pain in just the USA, this information could help 80 to 92 million or more of this group discover true pain relief without a prescription. We urge you to take the time to listen to this call a few times to really comprehend the full message being discussed. In 2014 MyNyloxin was awarded the 100% global marketing rights to not only the current Nyloxin Pain Relief product line, but also for the soon-to-be-released Pet Pain Away product line. This new pain relief product for dogs and cats will be the only product on the market that can be taken without side effects of stomach, liver or other complications. Not only is this a dream product line to people in the Network Marketing industry, but MyNyloxin has put a new twist on the industry by allowing its MIE base to participate in our multi-million dollar media campaign that directly markets to the public. This compensation plan pays up to 60% of the gross sales back to the MIE who are a part of the MyNyloxin Direct Response Media Division (MDRMD). If BIG PHARMA were to discover the true potential of this product, they would try to buy the rights to this product - most likely to keep it locked up and never make it available to the public. However, this amazing product still has 17 years left on its patent and can only be produced by Nutra Pharma Corporation, a publicly traded company trading under the symbol NPHC. The pain relief revolution is here, and we are proud to have you as part of our distribution team. MyNyloxin Team Leaders Recorded Conference Call : freeconferencing/playback.html?n=/storage/sgetFC/aOBlK/aIQ8xp Rik Deitsch Chairman and Chief Executive Officer Nutra Pharma Corporation Rik J Deitsch is the Chief Executive Officer of Nutra Pharma Corp., a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, autoimmune and infectious diseases as well as pain management. Mr. Deitsch was formerly in the Product Development department of the Rexall Sundown company and developed over 50 dietary supplements for the company. Mr. Deitsch is also the Founder and Chairman of DMH International, Inc., a medical software and device company specializing in PACS, EHR, EMR, and Paperless Medical Office Solutions. He holds both a B.S. in Chemistry and an M.S. in Biochemistry from Florida Atlantic University and has conducted research in collaboration with the Duke University Medical School Comprehensive Cancer Center and the Cleveland Clinic Cardiology Department. Mr. Deitsch is an adjunct professor and teaches several courses for Florida Atlantic Universitys College of Business and Continuing Education Department. He is also the co-author of two books: Are You Age-Wise, a guide to healthy aging; and Invisible Killers, a guide to environmental toxicity. Dr. Brad Eli Founder and Director San Diego Headache and Facial Pain Center Dr. Brad Eli is the Founder and Director of the San Diego Headache and Facial Pain Center, in Encinitas, California. Dr. Eli has 25 years of experience treating head and neck pain as well as sleep disorders. Dr. Bradley has developed a multi-disciplinary protocol to treat acute and chronic orofacial pain including migraines, stress and tension headaches, myofascial pain, neuralgia, temporomandibular disorders (TMD), burning tongue syndrome, and head and neck injuries. Dr. Eli will share the results of using Nyloxin, as a complimentary treatment approach, with his pain patients. Dr. Brad Eli is a nationally-recognized leader in sleep disorders treatment and pain management. His expertise in sleep led him to develop a patient-centered method that offers a variety of sleep treatment options and matches each patient with the best treatment for their symptoms and lifestyle. Patients diagnosed and treated by Dr. Eli consistently achieve better compliance rates and improved outcomes. Dr. Eli is the first Medicare- and Tricare-approved provider for multi-therapy sleep treatment in Southern California. Dr. Eli earned a post-doctoral Master’s Degree at UCLA where he received advanced training in sleep disorders. He remains the only expert with this unique skill set in the San Diego region. Dr. Eli is on the hospital staff at Scripps Memorial Hospital La Jolla and UCSD. He is a member of numerous professional associations including the American Academy of Sleep Medicine and the American Academy of Dental Sleep Medicine. He holds multiple patents in the fields of both sleep and pain. freeconferencing/playback.html?n=/storage/sgetFC/aOBlK/aIQ8xp&utm_source=355&utm_medium=email&utm_campaign=355
Posted on: Sun, 20 Jul 2014 07:04:13 +0000

Trending Topics



Recently Viewed Topics




© 2015